From DFT calculation to ML prediction, the potential catalysts with highly active and selective performance are efficiently screened by four ML models, i.e. decision tree, random forest, support ...

Phase Ib study of neoadjuvant concurrent chemoradiation plus durvalumab followed by surgery and adjuvant durvalumab for resectable stage III NSCLC. Results for miRNA-only XGBoost algorithm in held-out ...